The COVID-19 pandemic has triggered an unprecedented mobilization of resources to find vaccines and therapeutics to treat and prevent infection with SARS-CoV-2. mRNA technology was quickly adopted ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine ... 19 and flu in a single jab in a phase 1/2 trial, while a triple shot that also adds in ...